Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 2628 | 159 | 0.4965 | 0.3530 | 0.0605 | 0.0606 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1013 | 473 | 0.1348 | 0.1470 | 0.4669 | 0.4830 |
COLO 858 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 3 | 964 | 847 | 0.0355 | 0.0535 | 0.8786 | 0.8621 |
MZ7-mel | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 1537 | 88 | 0.2914 | 0.2872 | 0.0573 | 0.0593 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1227 | 649 | 0.1443 | 0.1543 | 0.5289 | 0.4970 |
A-375 | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 3 | 975 | 220 | 0.0411 | 0.0432 | 0.2256 | 0.2026 |
MZ7-mel | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1416 | 87 | 0.2673 | 0.3781 | 0.0614 | 0.0626 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 2042 | 430 | 0.4024 | 0.4161 | 0.2106 | 0.2078 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2006 | 239 | 0.0847 | 0.0889 | 0.1191 | 0.1262 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 3308 | 163 | 0.6325 | 0.5541 | 0.0493 | 0.0507 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 1251 | 376 | 0.2184 | 0.2060 | 0.3006 | 0.3157 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1480 | 1221 | 0.0786 | 0.0787 | 0.8250 | 0.7868 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 2847 | 207 | 0.5309 | 0.4729 | 0.0727 | 0.0666 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 1340 | 471 | 0.2169 | 0.2248 | 0.3515 | 0.3610 |
A-375 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 2124 | 82 | 0.1111 | 0.1343 | 0.0386 | 0.0352 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 1666 | 130 | 0.3089 | 0.4188 | 0.0780 | 0.0678 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 1388 | 504 | 0.2207 | 0.2193 | 0.3631 | 0.3870 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1677 | 72 | 0.0813 | 0.0917 | 0.0429 | 0.0407 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1425 | 70 | 0.2725 | 0.3555 | 0.0491 | 0.0539 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2673 | 333 | 0.5841 | 0.5745 | 0.1246 | 0.1322 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1037 | 892 | 0.0440 | 0.0609 | 0.8602 | 0.8549 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2625 | 208 | 0.4861 | 0.4216 | 0.0792 | 0.0846 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1604 | 415 | 0.2968 | 0.2889 | 0.2587 | 0.3083 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 3852 | 93 | 0.2045 | 0.1991 | 0.0241 | 0.0233 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 1879 | 128 | 0.3521 | 0.3242 | 0.0681 | 0.0687 |